Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3706402
Max Phase: Preclinical
Molecular Formula: C15H26N7O14P3S
Molecular Weight: 653.40
Molecule Type: Small molecule
Associated Items:
ID: ALA3706402
Max Phase: Preclinical
Molecular Formula: C15H26N7O14P3S
Molecular Weight: 653.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1ncnc2c1ncn2[C@@H]1O[C@H]([C@H](CSCCC(N)C(=O)O)OP(=O)(O)OP(=O)(O)NP(=O)(O)O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C15H26N7O14P3S/c16-6(15(25)26)1-2-40-3-7(35-39(32,33)36-38(30,31)21-37(27,28)29)11-9(23)10(24)14(34-11)22-5-20-8-12(17)18-4-19-13(8)22/h4-7,9-11,14,23-24H,1-3,16H2,(H,25,26)(H,32,33)(H2,17,18,19)(H4,21,27,28,29,30,31)/t6?,7-,9-,10+,11+,14+/m0/s1
Standard InChI Key: FBOLNTODBBAPDR-CHCQOLDJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 653.40 | Molecular Weight (Monoisotopic): 653.0471 | AlogP: -2.15 | #Rotatable Bonds: 14 |
Polar Surface Area: 345.25 | Molecular Species: ZWITTERION | HBA: 16 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.31 | CX Basic pKa: 9.50 | CX LogP: -8.12 | CX LogD: -15.14 |
Aromatic Rings: 2 | Heavy Atoms: 40 | QED Weighted: 0.08 | Np Likeness Score: 0.91 |
1. Kappler F, Hampton A.. (1990) Approaches to isozyme-specific inhibitors. 17. Attachment of a selectivity-inducing substituent to a multisubstrate adduct. Implications for facilitated design of potent, isozyme-selective inhibitors., 33 (9): [PMID:2391695] [10.1021/jm00171a032] |
2. Kappler F, Vrudhula VM, Hampton A.. (1988) Toward the synthesis of isozyme-specific enzyme inhibitors. Potent inhibitors of rat methionine adenosyltransferases. Effect of one-atom elongation of the ribose-P alpha bridge in two covalent adducts of L-methionine and beta,gamma-imido-ATP., 31 (2): [PMID:3257524] [10.1021/jm00397a020] |
3. Vrudhula VM, Kappler F, Afshar C, Ginell SL, Lessinger L, Hampton A.. (1989) Approaches to isozyme-specific inhibitors. 16. A novel methyl-C5' covalent adduct of L-ethionine and beta,gamma-imido-ATP as a potent multisubstrate inhibitor of rat methionine adenosyltransferases., 32 (4): [PMID:2784835] [10.1021/jm00124a026] |
Source(1):